Back to LLY
Bahl & Gaynor LLC LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
5
Latest value
$628.6M
Q3 2026
Peak value
$846.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $613.4M |
| Q4 2025 | $846.2M |
| Q1 2026 | $612.7M |
| Q2 2026 | $787M |
| Q3 2026 | $628.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $628.6M | 543.2K | — | — |
| Q2 2026 | $787M | 656.1K | — | — |
| Q1 2026 | $612.7M | 666.1K | — | — |
| Q4 2025 | $846.2M | 787.4K | — | — |
| Q3 2025 | $613.4M | 804.0K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B